RESOTRANS

This brand name is authorized in Mexico, New Zealand.

Active ingredients

The drug RESOTRANS contains one active pharmaceutical ingredient (API):

1	Prucalopride UNII 4V2G75E1CK - PRUCALOPRIDE SUCCINATE
	Prucalopride is a dihydrobenzofurancarboxamide with gastrointestinal prokinetic activities. Prucalopride is a selective, high affinity serotonin (5-HT4) receptor agonist, which is likely to explain its prokinetic effects.
	Read more about Prucalopride

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RESOTRANS Film-coated tablet	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A06AX05		A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AX Other laxatives
Discover more medicines within A06AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	066M2012
NZ	Medicines and Medical Devices Safety Authority	14731, 14733